Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 21.63
(-0.18%)
CNY 21.63
(-0.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 294.61 Million CNY | 497.63% |
| 2022 | 49.29 Million CNY | 3006.5% |
| 2021 | -1.69 Million CNY | 99.28% |
| 2020 | -235.81 Million CNY | -202.84% |
| 2019 | 229.29 Million CNY | -37.97% |
| 2018 | 369.66 Million CNY | -4.9% |
| 2017 | 388.71 Million CNY | 44.99% |
| 2016 | 268.1 Million CNY | 27.24% |
| 2015 | 210.7 Million CNY | -0.8% |
| 2014 | 212.41 Million CNY | -28.06% |
| 2013 | 295.26 Million CNY | 14.96% |
| 2012 | 256.83 Million CNY | 30.84% |
| 2011 | 196.29 Million CNY | 25.42% |
| 2010 | 156.51 Million CNY | 41.89% |
| 2009 | 110.3 Million CNY | 76.68% |
| 2008 | 62.43 Million CNY | 230.86% |
| 2007 | 18.87 Million CNY | 159.9% |
| 2006 | -31.5 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 91.11 Million CNY | -30.28% |
| 2024 Q2 | 38.39 Million CNY | -57.87% |
| 2024 Q3 | 103.53 Million CNY | 169.69% |
| 2023 Q1 | 33.51 Million CNY | -30.35% |
| 2023 Q3 | 69.16 Million CNY | 12.94% |
| 2023 FY | 294.61 Million CNY | 497.63% |
| 2023 Q4 | 130.69 Million CNY | 88.98% |
| 2023 Q2 | 61.23 Million CNY | 82.73% |
| 2022 FY | 49.29 Million CNY | 3006.5% |
| 2022 Q4 | 48.12 Million CNY | 475.16% |
| 2022 Q3 | 8.36 Million CNY | 179.65% |
| 2022 Q2 | -10.5 Million CNY | -304.22% |
| 2022 Q1 | -2.59 Million CNY | -121.05% |
| 2021 Q3 | -16.7 Million CNY | -131.09% |
| 2021 Q2 | 53.74 Million CNY | 271.59% |
| 2021 Q1 | -31.32 Million CNY | 80.49% |
| 2021 FY | -1.69 Million CNY | 99.28% |
| 2021 Q4 | 12.34 Million CNY | 173.88% |
| 2020 Q2 | 42.71 Million CNY | 142.51% |
| 2020 Q3 | 869.59 Thousand CNY | -97.96% |
| 2020 Q4 | -160.56 Million CNY | -18564.04% |
| 2020 FY | -235.81 Million CNY | -202.84% |
| 2020 Q1 | -100.48 Million CNY | -157.77% |
| 2019 Q2 | 82.86 Million CNY | 226.82% |
| 2019 FY | 229.29 Million CNY | -37.97% |
| 2019 Q4 | 173.92 Million CNY | 359.55% |
| 2019 Q3 | 37.84 Million CNY | -54.33% |
| 2019 Q1 | -65.33 Million CNY | 0.0% |
| 2018 FY | 369.66 Million CNY | -4.9% |
| 2017 FY | 388.71 Million CNY | 44.99% |
| 2016 FY | 268.1 Million CNY | 27.24% |
| 2015 FY | 210.7 Million CNY | -0.8% |
| 2014 FY | 212.41 Million CNY | -28.06% |
| 2013 Q1 | 56.75 Million CNY | 214.9% |
| 2013 Q2 | 81.77 Million CNY | 44.07% |
| 2013 Q3 | 75.49 Million CNY | -7.68% |
| 2013 FY | 295.26 Million CNY | 14.96% |
| 2012 Q2 | 63.2 Million CNY | -2.58% |
| 2012 FY | 256.83 Million CNY | 30.84% |
| 2012 Q4 | 18.02 Million CNY | -83.72% |
| 2012 Q3 | 110.72 Million CNY | 75.17% |
| 2012 Q1 | 64.88 Million CNY | 33.4% |
| 2011 Q2 | 52.39 Million CNY | 41.04% |
| 2011 Q4 | 48.63 Million CNY | -16.31% |
| 2011 Q1 | 37.15 Million CNY | -30.63% |
| 2011 FY | 196.29 Million CNY | 25.42% |
| 2011 Q3 | 58.11 Million CNY | 10.91% |
| 2010 Q1 | 23.31 Million CNY | 0.0% |
| 2010 Q2 | 36.05 Million CNY | 54.64% |
| 2010 Q4 | 53.55 Million CNY | 22.88% |
| 2010 FY | 156.51 Million CNY | 41.89% |
| 2010 Q3 | 43.58 Million CNY | 20.88% |
| 2009 FY | 110.3 Million CNY | 76.68% |
| 2008 FY | 62.43 Million CNY | 230.86% |
| 2007 FY | 18.87 Million CNY | 159.9% |
| 2006 FY | -31.5 Million CNY | 0.0% |